Sanofi-Regeneron’s Dupixent drug has received FDA approval for ‘smoker’s lungs’
The US Food and Drug Administration approved Sanofi and Regeneron. The companies said the blocker drug Dupixent is intended for patients with chronic lung disease, commonly known as ‘smoker’s lung.’
POPULAR POSTS
IEA warns ‘electricity era’ will come after fossil fuels peak
October 17, 2024
Easter Island fights global plastic waste vortex
October 17, 2024
Egypt opens more galleries at its antiquities museum
October 17, 2024
LIVE STREAM